loadpatents
name:-0.027566909790039
name:-0.016474962234497
name:-0.0025970935821533
KIM; Maeng Sup Patent Filings

KIM; Maeng Sup

Patent Applications and Registrations

Patent applications and USPTO patent grants for KIM; Maeng Sup.The latest application filed is for "anti-pd-1/anti-her2 natural antibody structural heterodimeric bispecific antibody and method of preparing same".

Company Profile
2.20.24
  • KIM; Maeng Sup - Beijing CN
  • Kim; Maeng Sup - Seoul KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-pd-1/anti-her2 Natural Antibody Structural Heterodimeric Bispecific Antibody And Method Of Preparing Same
App 20210032343 - LIU; Jiawang ;   et al.
2021-02-04
Chemical Compound, Pharmaceutical Composition Thereof, and Use and Application Thereof
App 20200172529 - ZHAO; Tao ;   et al.
2020-06-04
Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase
Grant 10,112,954 - Jung , et al. October 30, 2
2018-10-30
Fused pyrimidine derivatives for inhibition of tyrosine kinase activity
Grant RE46,511 - Cha , et al. August 15, 2
2017-08-15
Novel Fused Pyrimidine Derivatives For Inhibition Of Tyrosine Kinase Activity
App 20160229868 - CHA; Mi Young ;   et al.
2016-08-11
Fused pyrimidine derivatives for inhibition of tyrosine kinase activity
Grant 9,345,719 - Cha , et al. May 24, 2
2016-05-24
Thieno[3,2-d]pyrimidine derivatives having inhibitory activity on protein kinases
Grant 8,999,973 - Son , et al. April 7, 2
2015-04-07
Aminostyrylbenzofuran Derivatives As Inhibitors Against Beta-amyloid Fibril Formation, And Pharmaceutical Composition Comprising Same
App 20150065494 - Kim; Dong Jin ;   et al.
2015-03-05
Fused pyrimidine derivatives for inhibition of tyrosine kinase activity
Grant 8,957,065 - Cha , et al. February 17, 2
2015-02-17
Novel Fused Pyrimidine Derivatives For Inhibition Of Tyrosine Kinase Activity
App 20150045324 - CHA; Mi Young ;   et al.
2015-02-12
Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
Grant 8,940,908 - Bang , et al. January 27, 2
2015-01-27
Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof
Grant 8,846,699 - Ahn , et al. September 30, 2
2014-09-30
Quinoline or quinazoline derivatives with apoptosis inducing activity on cells
Grant 8,835,458 - Bae , et al. September 16, 2
2014-09-16
Novel Pyrimidine Derivative And Pharmaceutical Composition Including Same As An Active Ingredient
App 20140163226 - Park; Chul Hyun ;   et al.
2014-06-12
Method For Preparing Tetrazole Methanesulfonic Acid Salts, And Novel Compound Used In Same
App 20140148602 - BANG; Keuk Chan ;   et al.
2014-05-29
Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
Grant 8,680,277 - Bang , et al. March 25, 2
2014-03-25
Method for preparing entecavir and intermediate used therein
Grant 8,569,491 - Lee , et al. October 29, 2
2013-10-29
Quinoline Or Quinazoline Derivatives With Apoptosis Inducing Activity On Cells
App 20130165386 - Bae; In Hwan ;   et al.
2013-06-27
Novel Fused Pyrimidine Derivatives For Inhibition Of Tyrosine Kinase Activity
App 20130116213 - Cha; Mi Young ;   et al.
2013-05-09
THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON PROTEIN KINASES
App 20130053370 - Son; Jung Beom ;   et al.
2013-02-28
Method For Preparing Tetrazole Methanesulfonic Acid Salts, And Novel Compound Used In Same
App 20120330020 - Bang; Keuk Chan ;   et al.
2012-12-27
Bicyclic Heteroaryl Derivatives Having Inhibitory Activity For Protein Kinase
App 20120302567 - Jung; Seung Hyun ;   et al.
2012-11-29
Novel Method For Preparing Entecavir And Intermediate Used Therein
App 20120202998 - Lee; Jae Heon ;   et al.
2012-08-09
Amide derivative for inhibiting the growth of cancer cells
Grant 8,188,102 - Lee , et al. May 29, 2
2012-05-29
Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof
Grant 8,003,658 - Ham , et al. August 23, 2
2011-08-23
Styrylbenzofuran Derivatives As Inhibitors For Beta-amyloid Fibril Formation And Preparation Method Thereof
App 20110124888 - Kim; Dong Jin ;   et al.
2011-05-26
Novel Amide Derivative For Inhibiting The Growth Of Cancer Cells
App 20100179120 - Lee; Kwang-Ok ;   et al.
2010-07-15
P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
Grant 7,625,926 - Bang , et al. December 1, 2
2009-12-01
Quinazoline Derivatives as a Multiplex Inhibitor and Method For the Preparation Thereof
App 20080318950 - Ahn; Young-Gil ;   et al.
2008-12-25
1B-Methylcarbapenem Derivative and Process for the Preparation Thereof
App 20080039438 - Yoo; Kyung Ho ;   et al.
2008-02-14
Quinazoline Derivatives For Inhibiting Cancer Cell Growth And Method For The Preparation Thereof
App 20080009509 - Ham; Young Jin ;   et al.
2008-01-10
P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
App 20070072900 - Bang; Keuk Chan ;   et al.
2007-03-29
Process For The Preparation Of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1h- -imidazol-1-yl)methyl}-4h-carbazol-4-one
App 20020061919 - Lee, Kwang-Ok ;   et al.
2002-05-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed